Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Silo Pharma (SILO) Tax Provisions (2021 - 2023)

Silo Pharma (SILO) has disclosed Tax Provisions for 3 consecutive years, with $906396.0 as the latest value for Q1 2023.

  • Quarterly Tax Provisions rose 50.34% to $906396.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Mar 2023, changed N/A year-over-year, with the annual reading at $24876.0 for FY2021, N/A changed from the prior year.
  • Tax Provisions hit $906396.0 in Q1 2023 for Silo Pharma, up from $602909.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $906396.0 in Q1 2023 to a low of $5743.0 in Q4 2021.
  • Historically, Tax Provisions has averaged $383545.2 across 3 years, with a median of $311021.0 in 2021.
  • Biggest YoY gain for Tax Provisions was 50.34% in 2023; the steepest drop was 50.34% in 2023.
  • Year by year, Tax Provisions stood at $5743.0 in 2021, then surged by 10398.15% to $602909.0 in 2022, then skyrocketed by 50.34% to $906396.0 in 2023.
  • Business Quant data shows Tax Provisions for SILO at $906396.0 in Q1 2023, $602909.0 in Q1 2022, and $5743.0 in Q4 2021.